区域总监，医学联络官（美国东部）
Regional Director, Medical Science Liaison (US East)
Capricor Therapeutics (NASDAQ: CAPR) 是一家致力于推进针对罕见疾病的变革性细胞和外泌体疗法的生物技术公司。我们创新的核心是 Deramiocel（CAP-1002），这是我们在晚期开发阶段用于杜氏肌营养不良症（DMD）的领先细胞疗法。我们还利用专有的 StealthX™ 外泌体平台，解锁靶向递送和疫苗学领域的新可能。每个项目都体现了我们对科学边界的不断探索，并为最需要这些治疗的患者和家庭带来改变生命的疗法。
医学科学联络员（MSL）总监是一个基于现场的科学领导者，负责在指定区域内与全国和地区的权威专家（KOL）就杜氏肌营养不良症（DMD）和 DMD 心肌病进行科学交流。该职位专注于与神经肌肉疾病、心脏病学和儿科专科护理领域的思想领袖、治疗中心和学术机构进行科学交流；识别临床和研究机会；并把现场洞察转化为 Capricor 的 Deramiocel 医学策略。该职位与医学总监、医学事务副总裁、HEOR / RWE、药物警戒、临床开发以及整个美国 MSL 团队紧密合作。
职责
• 制定并执行区域 KOL/HCP 交流计划，包括识别、绘制和优先排序思想领袖、处方医生和治疗中心。
• 向 KOL 和 HCP 提供关于 Deramiocel 临床数据、DMD 心肌病现状和最新证据的科学演讲和交流。
• 支持顾问委员会、科学研讨会和 KOL 领导的研究项目。
• 在 HEOR / RWE 和医学总监的协调下，识别并支持由研究者发起的研究（IIS）和真实世界证据机会。
• 为医学会议提供科学支持，包括 DMD、神经肌肉、心脏病学和罕见病论坛。
• 收集并综合现场关于临床实践、治疗决策和最新证据的见解；将这些见解转化为医学策略的建议。
• 为内部利益相关者（销售、市场准入、患者服务）提供符合渠道和交流规则的科学培训和支持。
• 保持对 Deramiocel 临床数据、DMD 自然病史以及更广泛的治疗方案的全面科学理解。
查看英文原文
Capricor Therapeutics (NASDAQ: CAPR) is a biotechnology company dedicated to advancing transformative cell and exosome-based therapies for rare diseases. At the forefront of our innovation is Deramiocel (CAP-1002), our lead cell therapy in late-stage development for Duchenne muscular dystrophy. We are also harnessing our proprietary StealthX™ exosome platform to unlock new possibilities in targeted delivery and vaccinology. Every program reflects our commitment to pushing the boundaries of science and delivering life-changing treatments to patients and families who need them most.
The Medical Science Liaison (MSL) Director is a field-based scientific leader responsible for delivering Capricor's scientific engagement strategy across an assigned territory of national and regional KOLs treating Duchenne muscular dystrophy (DMD) and DMD cardiomyopathy. The role focuses on scientific exchange with thought leaders, treatment centers, and academic institutions in neuromuscular disease, cardiology, and pediatric specialty care; identification of clinical and research opportunities; and translation of field insights into Capricor's medical strategy for Deramiocel. This individual partners closely with the Medical Director, VP Medical Affairs, HEOR / RWE, Pharmacovigilance, Clinical Development, and the broader U.S. MSL team.
Responsibilities
• Develop and execute the territory KOL/HCP engagement plan, including identification, mapping, and prioritization of thought leaders, prescribers and treatment centers.
• Deliver scientific presentations and engage in scientific exchange with KOLs and HCPs on Deramiocel clinical data, the DMD cardiomyopathy landscape, and emerging evidence.
• Support advisory boards, scientific symposia, and KOL-led research initiatives.
• Identify and support investigator-initiated studies (IIS) and real-world evidence opportunities in coordination with HEOR / RWE and Medical Director.
• Provide scientific support for medical congresses, including DMD, neuromuscular, cardiology, and rare-disease forums.
• Collect and synthesize field insights on clinical practice, treatment decision-making, and emerging evidence; translate insights into recommendations for medical strategy.
• Provide scientific training and support to internal stakeholders (Sales, Market Access, Patient Services) in compliance with channel and engagement rules.
• Maintain comprehensive scientific fluency on Deramiocel clinical data, DMD natural history, and the broader treatment landscape.
• Ensure timely reporting of adverse events and product complaints in line with company and regulatory processes.
• Document field activities, KOL/HCP engagement, and insights in Capricor's medical CRM in compliance with standards.
• Ensure all activities follow FDA, OIG, PhRMA Code, ACCME, and Capricor compliance standards.
• Perform other duties as may be assigned from time to time.
Required Qualifications
• Advanced clinical degree required (MD, PharmD, PhD, DO, or equivalent).
• 5 to 10 years of MSL experience in biotech / pharma; experience in rare disease, cell / gene therapy, pediatrics, neuromuscular disease, or cardiology preferred.
• Established scientific credibility and ability to engage KOLs in peer-to-peer scientific exchange.
• Strong working knowledge of FDA, OIG, PhRMA Code, ACCME, and MLR review processes.
• Excellent written and verbal scientific communication skills, including ability to deliver complex data to clinical audiences.
• Self-directed execution and the ability to operate independently in a field-based environment.
Preferred Qualifications
• Existing relationships across the DMD treatment center network, neuromuscular community, or pediatric cardiology community.
• Prior launch experience in rare disease, cell / gene therapy, pediatrics, rare cardiology or neuromuscular disease.
• Experience operating in a pre-commercial or early-commercial company.
Competency Definitions
• Strong problem-solving and decision-making ability.
• Vendor management and negotiation skills.
• Ability to work in a fast-paced, rapidly scaling environment.
• Exceptional attention to detail and documentation discipline.
• Ability to influence without authority across cross-functional teams.
Working Conditions
• Field-based (remote) position based in or near the assigned territory; territory geography determined at hire.
• Domestic travel approximately 60 to 75% for KOL engagement, advisory boards, congresses, and internal planning.
• Periodic presence at Capricor's San Diego HQ as required by business need.
Why Capricor?
Capricor Therapeutics is advancing cell and exosome-based therapies with a focus on serious diseases where patients and families need new treatment options. Our work is grounded in scientific rigor, collaboration, and a shared commitment to moving meaningful therapies forward. Joining Capricor means being part of a mission-driven team working at the intersection of innovation, execution, and patient impact.
Come Work With Us
At Capricor, you’ll join a collaborative environment where employees are encouraged to contribute, grow, and help build the systems, science, and operations needed to support our next stage of growth. We value people who are thoughtful, accountable, hands-on, and motivated by work that can make a real difference.
Recruiting Fraud Notice
Capricor does not use Skype for interviews or recruiting activities. Candidates will only be contacted by someone using an official Capricor email address ending in @capricor.com. Capricor will never ask candidates to send money, deposit a check, purchase equipment, or provide payment for any reason as part of the recruiting or onboarding process.
Notice to Recruiting Agencies
Capricor Therapeutics does not accept candidate submissions or referrals from recruiting agencies, staffing firms, or third-party recruiters without express written approval from Talent Acquisition and a fully executed agreement with Capricor. Agencies that contact hiring managers directly, solicit business, or submit candidates without prior approval will not be considered for engagement. Any unsolicited submissions will become the property of Capricor Therapeutics, and no fees will be paid for candidates hired as a result of such submissions. We appreciate your cooperation and respect for this policy.
Originally posted on Himalayas